NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

A call for health advocacy groups to disclose more about the pharma money they take

Posted By


A study in the American Journal of Public Health looks at drug industry contributions to non-profit health advocacy groups. The authors report:

“We used Eli Lilly and Company’s grant registry to examine its grant-giving policies. We also examined (health advocacy organization) Web sites to determine their grant disclosure patterns. Only 25% of (health advocacy organizations) that received Lilly grants acknowledged Lilly’s contributions on their Web sites, and only 10% acknowledged Lilly as a grant event sponsor. No (health advocacy organization) disclosed the exact amount of a Lilly grant. As highly trusted organizations, (health advocacy organizations) should disclose all corporate grants, including the purpose and the amount. Absent this disclosure, legislators, regulators, and the public cannot evaluate possible conflicts of interest or biases in HAO advocacy.”

ProPublica, which has been doing a lot of reporting on conflicts of interest in health care, posted the study and its story on the study.

You might also like


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.